Search Results

You are looking at 181 - 190 of 484 items for :

  • Refine by Access: All x
Clear All
Full access

Ju Dong Yang, Michael Luu, Amit G. Singal, Mazen Noureddin, Alexander Kuo, Walid S. Ayoub, Vinay Sundaram, Honore Kotler, Irene K. Kim, Tsuyoshi Todo, Georgios Voidonikolas, Todd V. Brennan, Kambiz Kosari, Andrew S. Klein, Andrew Hendifar, Shelly C. Lu, Nicholas N. Nissen, and Jun Gong

, contrast-enhanced CT or MRI scan is sometimes used as a surveillance test in high-risk individuals. 8 The American Association for the Study of Liver Diseases (AASLD) endorsed an HCC surveillance program for high-risk patients with its first HCC practice

Full access

Ryan M. Kahn, Sushmita Gordhandas, Emeline Aviki, and Kara Long Roche

deny coverage for individuals at risk. Patients, physicians, and advocacy groups have identified breast MRI in carriers of HBOC and colonoscopies for younger individuals with Lynch syndrome as the most difficult services to obtain. 2 , 3 Difficulty in

Full access

Matthew Barth, Ana C. Xavier, Saro Armenian, Anthony N. Audino, Lindsay Blazin, David Bloom, Jong Chung, Kimberly Davies, Hilda Ding, James B. Ford, Paul J. Galardy, Rabi Hanna, Robert Hayashi, Cathy Lee-Miller, Andrea Judit Machnitz, Kelly W. Maloney, Lianna Marks, Paul L. Martin, David McCall, Martha Pacheco, Anne F. Reilly, Mikhail Roshal, Sophie Song, Joanna Weinstein, Sara Zarnegar-Lumley, Nicole McMillian, Ryan Schonfeld, and Hema Sundar

, and pelvis (see PBCL-3 , page 1270). FDG-PET/CT or FDG-PET/MRI is recommended if available. 25 However, treatment should not be delayed to obtain this scan, and FDG-PET does not exclude the need for full diagnostic quality, high-resolution CT or MRI

Full access

Gregory P. Kalemkerian, Billy W. Loo Jr, Wallace Akerley, Albert Attia, Michael Bassetti, Yanis Boumber, Roy Decker, M. Chris Dobelbower, Afshin Dowlati, Robert J. Downey, Charles Florsheim, Apar Kishor P. Ganti, John C. Grecula, Matthew A. Gubens, Christine L. Hann, James A. Hayman, Rebecca Suk Heist, Marianna Koczywas, Robert E. Merritt, Nisha Mohindra, Julian Molina, Cesar A. Moran, Daniel Morgensztern, Saraswati Pokharel, David C. Portnoy, Deborah Rhodes, Chad Rusthoven, Jacob Sands, Rafael Santana-Davila, Charles C. Williams Jr, Karin G. Hoffmann, and Miranda Hughes

fractionation schemes. The survival advantage of PCI was recently challenged by a randomized phase III Japanese trial of 224 patients with extensive-stage SCLC. 25 Patients were required to have an MRI before PCI to confirm the absence of brain metastases and

Full access

Antonio Di Meglio, Nancy U. Lin, Rachel A. Freedman, William T. Barry, Eric P. Winer, and Ines Vaz-Luis

day 1 of first-line treatment. Specifically, we examined (1) imaging modality used (chest/abdomen/pelvis CT, bone scan, 18 F-fluorodeoxyglucose [FDG]-PET/PET-CT, abdominal MRI, abdominal ultrasound, chest radiograph, spine MRI, head CT, brain MRI); (2

Full access

Ralph Hauke

Roentgenol 1988 ; 151 : 497 – 501 . 16. Choyke PL . Detection and staging of renal cancer . Magn Reson Imaging Clin N Am 1997 ; 5 : 29 – 47 . 17. Janus CL Mendelson DS . Comparison of MRI and CT for study of renal and perirenal

Full access

Harold J. Burstein

matter of days or a few weeks before death. In my hospital network, hospitalization functions as a complicated catalyst for these transitions. Urgent testing, including diagnostic laboratory studies or CT and MRI scans, is more readily available at any

Full access

Pamela J. DiPiro

examples of this use in breast cancer imaging, including MRI enhancement characteristics with specific tumor molecular subtypes or imaging with targeted monoclonal antibodies linked to PET agents to more clearly elucidate specific tumor expression, 10 in

Full access

Jeffrey S. Montgomery, David C. Miller, and Alon Z. Weizer

, lowering the imaging sensitivity for these findings. Cross-sectional imaging with either a CT scan or an MRI evaluates the local disease burden and assesses for nodal and distant metastases. The accuracy of CT and an MRI for staging the local extent of

Full access

clinical response signals in a broad array of solid tumors Evaluate whether dynamic contrast-enhanced MRI, to determine the degree of vascular permeability, and PET scan, to delineate tumor viability and glucose uptake, are able to predict major